4.7 Review

PEGylation for enhancing nanoparticle diffusion in mucus

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 124, 期 -, 页码 125-139

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.addr.2017.08.010

关键词

Mucus; Mucus barrier; PEG; Nanoparticle; Mucus-penetrating; Muco-inert; Diffusivity

资金

  1. National Science Foundation Graduate Research Fellowship Program [DGE-1650116]
  2. National Science Foundation CAREER Award [DMR-1151477]
  3. David and Lucile Packard Foundation [2013-39274]
  4. Eshelman Institute for Innovation
  5. UNC Research Opportunities Initiative grant in Pharmacoengineering

向作者/读者索取更多资源

The viscoelastic mucus secretions coating exposed organs such as the lung airways and the female reproductive tract can trap and quickly eliminate not only foreign pathogens and ultrafine particles but also particle-based drug delivery systems, thus limiting sustained and targeted drug delivery at mucosal surfaces. To improve particle distribution across the mucosa and enhance delivery to the underlying epithelium, many investigators have sought to develop nanoparticles capable of readily traversing mucus. The first synthetic nanoparticles shown capable of rapidly penetrating physiological mucus secretions utilized a dense coating of polyethylene glycol (PEG) covalently grafted onto the surface of preformed polymeric nanoparticles. In the decade since, PEG has become the gold standard in engineering mucus-penetrating drug carriers for sustained and targeted drug delivery to the lungs, gastrointestinal tract, eyes, and female reproductive tract. This review summarizes the history of the development of various PEG-based mucus-penetrating particles, and highlights the key physicochemical properties of PEG coatings and PEGylation strategies to achieve muco-inert PEG coatings on nanoparticle drug carriers for improved drug and gene delivery at mucosal surfaces. (C) 2017 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据